Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Namvar

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Heliyon|September 4, 2023
Immunoinformatics studies of heat shock proteins 27 and 70: Development of potent therapeutic vaccine constructs against human papillomavirus-related cancersFatemeh Rezaei, Ali Namvar, Elahe Akbari, et al.
Hematology (Amsterdam, Netherlands)|February 14, 2019
Analysis of long non-coding RNA expression in hemophilia A patientsNiloofar Naderi, Ali Namvar, Nooshin Amani, et al.
Acta Psychologica|December 10, 2025
Effectiveness of adoption-specific therapy on behavioral problems and attachment in adopted children and parental stress in adoptive families: A randomized controlled trialAli Namvar Arefi, Mohammadreza Pirmoradi, Komeil Zahedi Tajrishi, et al.
Hematology (Amsterdam, Netherlands)|July 12, 2018
Polymorphisms in the TGF-β1 (rs1982037) and IL-2 (rs2069762, rs4833248) genes are not associated with inhibitor development in Iranian patients with hemophilia ANiloofar Naderi, Fariba Ebrahimzadeh, Mohammad Jazebi, et al.
Expert Review of Anti-Infective Therapy|May 21, 2022
Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIVElahe Taki, Faezeh Soleimani, Arezoo Asadi, et al.
Journal of Medical Virology|February 8, 2019
Human platelet antigens polymorphisms; association to the development of liver fibrosis in patients with chronic hepatitis CAli Ghasemi, Maryam Zadsar, Mojgan Shaiegan, et al.
Biotechnology Letters|May 14, 2021
In silico design and in vitro expression of novel multiepitope DNA constructs based on HIV-1 proteins and Hsp70 T-cell epitopesElahe Akbari, Kimia Kardani, Ali Namvar, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 19, 2021
Genetic analysis of non-severe hemophilia A phenotype with A discrepancy between one-stage and chromogenic factor VIII activity assaysAmir Valikhani, Mojgan Mirakhorly, Ali Namvar, et al.
Virology Journal|October 8, 2021
Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disordersHeidar Sharafi, Bita Behnava, Alireza Azizi-Saraji, et al.
Journal of Medical Virology|September 12, 2018
Acute changes in cardiac function by direct acting antiviral therapy for hepatitis C-infected patients with thalassemiaArezoo Khosravi, Hamidreza Karimi-Sari, Mahdi Abedi-Andani, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Heliyon|September 4, 2023
Immunoinformatics studies of heat shock proteins 27 and 70: Development of potent therapeutic vaccine constructs against human papillomavirus-related cancersFatemeh Rezaei, Ali Namvar, Elahe Akbari, et al.
Hematology (Amsterdam, Netherlands)|February 14, 2019
Analysis of long non-coding RNA expression in hemophilia A patientsNiloofar Naderi, Ali Namvar, Nooshin Amani, et al.
Acta Psychologica|December 10, 2025
Effectiveness of adoption-specific therapy on behavioral problems and attachment in adopted children and parental stress in adoptive families: A randomized controlled trialAli Namvar Arefi, Mohammadreza Pirmoradi, Komeil Zahedi Tajrishi, et al.
Hematology (Amsterdam, Netherlands)|July 12, 2018
Polymorphisms in the TGF-β1 (rs1982037) and IL-2 (rs2069762, rs4833248) genes are not associated with inhibitor development in Iranian patients with hemophilia ANiloofar Naderi, Fariba Ebrahimzadeh, Mohammad Jazebi, et al.
Expert Review of Anti-Infective Therapy|May 21, 2022
Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIVElahe Taki, Faezeh Soleimani, Arezoo Asadi, et al.
Journal of Medical Virology|February 8, 2019
Human platelet antigens polymorphisms; association to the development of liver fibrosis in patients with chronic hepatitis CAli Ghasemi, Maryam Zadsar, Mojgan Shaiegan, et al.
Biotechnology Letters|May 14, 2021
In silico design and in vitro expression of novel multiepitope DNA constructs based on HIV-1 proteins and Hsp70 T-cell epitopesElahe Akbari, Kimia Kardani, Ali Namvar, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 19, 2021
Genetic analysis of non-severe hemophilia A phenotype with A discrepancy between one-stage and chromogenic factor VIII activity assaysAmir Valikhani, Mojgan Mirakhorly, Ali Namvar, et al.
Virology Journal|October 8, 2021
Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disordersHeidar Sharafi, Bita Behnava, Alireza Azizi-Saraji, et al.
Journal of Medical Virology|September 12, 2018
Acute changes in cardiac function by direct acting antiviral therapy for hepatitis C-infected patients with thalassemiaArezoo Khosravi, Hamidreza Karimi-Sari, Mahdi Abedi-Andani, et al.
Pageof 3